Search Results - Bloomenstein, Marc R

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Improved Signs and Symptoms of Dry Eye Disease for Restasis ® Patients Following a Single Tearcare ® Treatment: Phase 2 of the SAHARA Study

    Improved Signs and Symptoms of Dry Eye Disease for Restasis ® Patients Following a Single Tearcare ® Treatment: Phase 2 of the SAHARA Study by Ayres, Brandon D, Bloomenstein, Marc R, Loh, Jennifer, Chester, Thomas, Saenz, Bobby, Echegoyen, Julio, Kannarr, Shane R, Rodriguez, Tomasita C, Dickerson, Jr, Jaime E

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    A Randomized, Controlled Trial Comparing Tearcare ® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA) [Response To Letter]

    A Randomized, Controlled Trial Comparing Tearcare ® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA) [Response To Letter] by Ayres, Brandon D, Bloomenstein, Marc R, Loh, Jennifer, Chester, Thomas, Saenz, Bobby, Ehegoyen, Julio, Kannarr, Shane R, Perez, Victor L, Rodriguez, Tomasita C, Dickerson, Jr, Jaime E

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    A Randomized, Controlled Trial Comparing Tearcare ® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA)

    A Randomized, Controlled Trial Comparing Tearcare ® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA) by Ayres, Brandon D, Bloomenstein, Marc R, Loh, Jennifer, Chester, Thomas, Saenz, Bobby, Echegoyen, Julio, Kannarr, Shane R, Perez, Victor L, Rodriguez, Tomasita C, Dickerson, Jr, Jaime E

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Improved Signs and Symptoms of Dry Eye Disease for Restasis® Patients Following a Single Tearcare® Treatment: Phase 2 of the SAHARA Study

    Improved Signs and Symptoms of Dry Eye Disease for Restasis® Patients Following a Single Tearcare® Treatment: Phase 2 of the SAHARA Study by Ayres, Brandon D, Bloomenstein, Marc R, Loh, Jennifer, Chester, Thomas, Saenz, Bobby, Echegoyen, Julio, Kannarr, Shane R, Rodriguez, Tomasita C, Dickerson, Jaime E

    Get full text
    Report
    Save to List
    Saved in:
  5. 5
    A Randomized, Controlled Trial Comparing Tearcare® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA)

    A Randomized, Controlled Trial Comparing Tearcare® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA) by Ayres, Brandon D, Bloomenstein, Marc R, Loh, Jennifer, Chester, Thomas, Saenz, Bobby, Echegoyen, Julio, Kannarr, Shane R, Perez, Victor L, Rodriguez, Tomasita C, Dickerson, Jaime E

    Get full text
    Report
    Save to List
    Saved in:
  6. 6
    Neural adaptation in refractive care

    Neural adaptation in refractive care by Bloomenstein, Marc R

    Published in Optometry times
    Get full text
    Magazinearticle
    Save to List
    Saved in:
  7. 7
    More optometrists are using amniotic membrane

    More optometrists are using amniotic membrane by Bloomenstein, Marc R

    Published in Optometry times
    Get full text
    Magazinearticle
    Save to List
    Saved in:
  8. 8
    Managing cooperatively with patients: Being a selfless provider will earn you trust and loyalty

    Managing cooperatively with patients: Being a selfless provider will earn you trust and loyalty by Bloomenstein, Marc R

    Published in Optometry times
    Get full text
    Magazinearticle
    Save to List
    Saved in:
  9. 9
    Educating patients on refractive surgery options

    Educating patients on refractive surgery options by Bloomenstein, Marc R

    Published in Optometry times
    Get full text
    Magazinearticle
    Save to List
    Saved in:
  10. 10
    Perception and quality of life associated with the use of olopatadine 0.2% (Pataday) in patients with active allergic conjunctivitis

    Perception and quality of life associated with the use of olopatadine 0.2% (Pataday) in patients with active allergic conjunctivitis by Scoper, Stephen V, Berdy, Gregg J, Lichtenstein, Steven J, Rubin, Jay M, Bloomenstein, Marc, Prouty, Robert E, Vogelson, Cullen T, Edwards, Michael R, Waycaster, Curtis, Pasquine, Terri, Gross, Robert D, Robertson, Stella M

    Published in Advances in therapy
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: